MedPath

A Clinical study to evaluate effect of single ayurvedic drug therapy in Pandu (Iron deficiency Anaemia)

Phase 2
Conditions
Health Condition 1: D759- Disease of blood and blood-formingorgans, unspecifiedHealth Condition 2: D759- Disease of blood and blood-formingorgans, unspecified
Registration Number
CTRI/2024/02/062297
Lead Sponsor
Tilak Ayurved Mahavidyalaya,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women of reproductive age group of 15 to 49 years

patients diagnosed with iron deficiency anaemia

patients having symptoms of panduta, dourbalya, shwas,hritspandan, akshi koot shoth

patients having haemoglobin less than 12

Exclusion Criteria

patients having haemoglobin less than 7

patient suffering from haematological disorder,gynacological diseases and systemic disorders

pregnant females and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Minimum 50% increase in Hb should be observed after the completion of the trial in 60 daysTimepoint: Baseline, 15th day, 30th day, 45th day, 60th day
Secondary Outcome Measures
NameTimeMethod
recurrence of pallor,generalized weakness, dyspnoea,giddinesTimepoint: 60 days
© Copyright 2025. All Rights Reserved by MedPath